Earnings Ahead

HRMY - Harmony Biosciences Holdings Inc

34.89 -0.77 -2.16

Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

About

Profile


Headquarters

Pennsylvania, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

HRMY



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Harmony Biosciences Non-GAAP EPS of $0.73 misses by $0.18, revenue of $168.4M in-line
  • Harmony Biosciences Q4 2023 Earnings Preview
  • Harmony gets FDA orphan drug status for Prader-Willi treatment
  • Harmony Biosciences says Q4 preliminary net product revenue was about $168M
  • Bank of America more favorable on SMID-cap biotechs into 2024
  • Harmony Biosciences Non-GAAP EPS of $0.97 beats by $0.16, revenue of $160.3M beats by $11.69M
  • Mizuho says market fears for Harmony's Wakix drug are "overblown"
  • Harmony Biosciences subsidiary extends expiration of offer to acquire Zynerba
  • Harmony Bio falls as Goldman Sachs cuts to Sell on revenue risks
  • Harmony Bio expects FDA to reject citizen petition on sleep therapy
  • Berenberg starts Harmony Biosciences at buy, cites upcoming Phase 3 data
  • Harmony Bio nabs FDA orphan drug tag for neuro candidate
  • Harmony Biosciences gains as challenge to Wakix patent rejected
  • Zynerba surges on $200M buyout deal with Harmony Biosciences
  • Harmony Biosciences announces $125M buyback
  • Harmony Biosciences Non-GAAP EPS of $0.76 beats by $0.02, revenue of $134.2M misses by $7.84M
  • Harmony Biosciences enters into $185M term loan facility
  • Harmony Biosciences Non-GAAP EPS of $0.66 beats by $0.10, revenue of $119.13M beats by $2.94M
  • Harmony Biosciences appoints CEO
  • Harmony Biosciences a neutral at BofA on reliance on Wakix narcolepsy drug

Earnings History

Date EPS / Forecast Revenue / Forecast
November 9, 2021 0.51 / 0.3 80.73M / 79.75M Beat!
August 10, 2021 0.24 / 0.1767 73.82M / 68.83M Beat!
May 11, 2021 0.13 / -0.0267 59.67M / 57.2M Beat!
March 25, 2021 - / 0.0767 56.29M / 51.89M Beat!
November 12, 2020 -0.14 / -0.0467 45.61M / 40M Beat!
September 2, 2020 - / - 38M / - Beat!
August 6, 2020 -1.57 / - 6.00M / - Beat!
Date Price Open High Low Vol Change ER
Feb 28 39.96 37.99
41.11
37.99
761.44K 5.35%
Feb 25 37.93 37.46
38.51
36.50
249.26K 1.47%
Feb 24 37.38 34.99
37.51
34.45
249.20K 2.38%
Feb 23 36.51 37.99
38.25
36.37
167.70K -3.08%
Feb 22 37.67 38.04
38.56
37.10
175.05K -1.95%
 
Feb 18 38.42 38.97
39.82
37.86
173.61K -1.96%
Feb 17 39.19 39.64
40.07
38.92
160.53K -2.05%
Feb 16 40.01 39.53
40.25
39.02
148.64K 0.65%
Feb 15 39.75 38.46
39.88
38.46
183.03K 4.80%
Feb 14 37.93 37.28
39.49
35.58
289.59K 2.62%
Feb 11 36.96 38.04
38.58
36.73
372.66K -2.61%
Feb 10 37.95 38.08
39.66
37.58
218.95K -2.79%
Feb 9 39.04 38.82
39.68
37.88
192.96K 1.72%
Feb 8 38.38 37.74
38.60
36.99
217.52K 0.89%
Feb 7 38.04 37.99
38.77
37.73
210.02K -0.18%
Feb 4 38.11 36.87
38.71
36.65
432.38K 2.97%
Feb 3 37.01 37.26
38.35
36.68
189.04K -2.66%
Feb 2 38.02 37.75
38.56
37.10
263.54K 1.22%
Feb 1 37.56 36.06
37.86
35.17
304.07K 4.74%